Butterfly Network, Inc. develops semiconductor-based ultrasound devices, programmable cloud software and AI for medical imaging and sensing. Its Ultrasound-on-Chip technology underpins handheld whole-body ultrasound systems such as Butterfly iQ, iQ+ and iQ3, along with enterprise workflow software including Compass AI and developer tools such as Butterfly Garden.
Company news commonly covers financial results, point-of-care ultrasound adoption, FDA-cleared AI tools such as its Gestational Age Tool, U.S. and international sales channels, and platform initiatives. Updates also address Butterfly Embedded, the company’s licensing and co-development effort for applying its ultrasound chip and software platform in partner-built products, as well as board and leadership changes tied to medtech, clinical strategy and commercialization.
Summary not available.
Summary not available.
Butterfly Network, an innovative digital health company, is set to present at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021, at 9:30 AM ET. The company will discuss its plans to enhance access to ultrasound technology. Butterfly Network will be listed on the NYSE under the ticker BFLY following a merger with Longview Acquisition Corp (NYSE: LGVW). The leadership team, including CEO Laurent Faracci and CMO Dr. John Martin, aims to democratize medical imaging globally, particularly for the 4.7 billion people currently lacking ultrasound access.